Your shopping cart is currently empty

PEG-DPCA conjugate 1 is a PEG-DPCA compound that can co-assemble with mPEG-Amide-tri(DPCA) to form a supramolecular polymer hydrogel with a nanofiber structure. This hydrogel exhibits shear-thinning properties, making it suitable for injectable drug delivery, and it boasts a high drug-loading capacity. It degrades in vivo to release only DPCA and PEG, promoting regeneration in difficult-to-heal adult mouse ear holes. PEG-DPCA conjugate 1 is applicable in tissue regeneration research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | PEG-DPCA conjugate 1 is a PEG-DPCA compound that can co-assemble with mPEG-Amide-tri(DPCA) to form a supramolecular polymer hydrogel with a nanofiber structure. This hydrogel exhibits shear-thinning properties, making it suitable for injectable drug delivery, and it boasts a high drug-loading capacity. It degrades in vivo to release only DPCA and PEG, promoting regeneration in difficult-to-heal adult mouse ear holes. PEG-DPCA conjugate 1 is applicable in tissue regeneration research. |
| Cas No. | 2459303-78-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.